BACKGROUND: Determine-TB LAM assay is a urine point-of-care test useful for TB diagnosis in HIV-positive patients. We assessed the incremental diagnostic yield of adding LAM to algorithms based on clinical signs, sputum smear-microscopy, chest X-ray and Xpert MTB/RIF in HIV-positive patients with symptoms of pulmonary TB (PTB).
METHODS: Prospective observational cohort of ambulatory (either severely ill or CD4
RESULTS: Among 474 patients included, 44.1% were severely ill, 69.6% had CD4
CONCLUSION: LAM should be included in TB diagnostic algorithms in parallel to microscopy or Xpert request for HIV-positive patients either ambulatory (severely ill or CD4